data showing less than 4% cross-reactivity of this anti-T4 forT3 (see Table 1 ). Although the absorption controls indicated that this antibody does bind T4, the cross-reactivity for T3 in tissue makes it impossible to tell how much, if any, of the observed tissue fluorescence is due to specific binding of T4, as opposed to non-specific binding at T3 antigenic sites. Therefore, while it is unclear how much of the observed reaction indicates the presence of T4, T3 is clearly present at specific sites in the thyroid gland. In summary, the present study demonstrates that immunofluorescence techniques can be used to define sites at which T3 can be found within the thyroid gland. These sites correspond to immunocytochemical localizations of thyroglobulin (S-8), and to autoradiographically-determined sites of 125! deposition in follicular cells and colloid pools (3, 7). The availability of highly specific T3 antisera provides a powerful tool to examine the manner in which T3 binds to its target cells and, thereby, possibly regulates metabolic events in these cells.
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